Whether it’s new ways to diagnose cancer, the creation of bionic limbs or innovative ways to treat the growing number of people with diabetes, the UK has a world leading life sciences sector. Why is the EIS so important to these success stories, and how can the schemes continue to unlock global scientific breakthroughs?
Chair: Elliot Gulliver-Needham, City AM
Panel: Steve Bates OBE, BioIndustry Association Mark Beaumont, Eos Advisory Anne Dobrée, Parkwalk Advisors Dr. James Groves, Imperial College London Sunil Shah, o2h Ventures